Article Details
Retrieved on: 2022-06-24 12:12:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech (NASDAQ: BNTX) received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for its product candidate BNT211 ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here